Do intra-articular therapies work and who will benefit most?
The main intra-articular (IA) treatments used in osteoarthritis are corticosteroids and hyaluronan injections. Data concerning their short- and long-term efficacy and their potential side-effects are reviewed here. IA corticosteroids are effective for reducing short-term pain and appear to have no long-term deleterious effects on the cartilage; they may be more efficacious in patients with joint effusion and/or symptom flares. IA hyaluronan have a modest but long-lived symptomatic effect on pain and functional outcome in knee osteoarthritis; the level of evidence is poor concerning their efficacy in other joints. The differences in efficacy related to the molecular weight of the hyaluronan are a subject of debate. There is a risk of acute painful reactions, which seem more frequent with higher-molecular-weight hyaluronan. Some data--mainly from animal studies--suggest a possible long-term chondroprotective effect of hyaluronan. This treatment seems more efficacious in non-radiologically severe osteoarthritis with no or mild effusion.
Service de Rhumatologie B, Hôpital Cochin, René Descartes University, 27 rue du Faubourg Saint Jacques, 75014 Paris, France. laure.gossec@cch.aphp.fr
Laure
L
Gossec
Maxime
M
Dougados
D000276:Adjuvants, Immunologic / Q000008:administration & dosage*; D005938:Glucocorticoids / Q000008:administration & dosage*; D006801:Humans; D006820:Hyaluronic Acid / Q000008:administration & dosage*; D007270:Injections, Intra-Articular; D010003:Osteoarthritis / Q000188:drug therapy*; D016896:Treatment Outcome
D000276:Adjuvants, Immunologic; D005938:Glucocorticoids; D006820:Hyaluronic Acid